Summary 摘要
Novo Nordisk's stock continues to surge as greedy investors exploit surging momentum, as they fear missing out on further potential gains.
$诺和诺德(NVO)$ 的股价继续飙升，因为贪婪的投资者担心错过更多的潜在收益，从而利用飙升的势头。
The company's impressive Q3 earnings results suggest the upward momentum could continue. I also have not assessed sell signals that could stall its momentum yet.
该公司令人印象深刻的第三季度财报表明，上升势头可能会继续。我也还没有评估出可能阻碍其发展势头的卖出信号。
Novo Nordisk's plans to broaden its geographical coverage and expand its production capacity should support investors' confidence in sustainable demand/supply dynamics.
诺和诺德公司扩大地理覆盖范围和扩大生产能力的计划应能增强投资者对可持续供需动态的信心。
However, investors must not ignore the risks of over-optimism at the current levels that could set the stage for a massive reality check.
然而，投资者绝不能忽视在当前水平上过度乐观的风险，因为这可能为大规模的现实检查埋下伏笔。
I explain the key levels I'm watching and urge investors with zero or little exposure to be patient and wait out the FOMO surge.
我解释了我正在观察的关键水平，并敦促没有或很少接触的投资者保持耐心，等待 FOMO 激增。
沉浸式翻译双语全文：网页链接